Persistence of Haloperidol in the Brain
- 1 September 1988
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of General Psychiatry
- Vol. 45 (9) , 879-880
- https://doi.org/10.1001/archpsyc.1988.01800330113019
Abstract
To the Editor.— A growing body of evidence suggests that the effects of neuroleptic drugs may persist long after termination of treatment. Side effects, including the life-threatening neuroleptic malignant syndrome,1have been reported to last for days to weeks after medication is discontinued,2,3and clinical relapse, even in chronically ill patients, may not occur for weeks or months after administration of the drug is stopped.4A parallel phenomenon is evident in animals: rats given single, moderate doses of haloperidol exhibited signs of central dopaminergic blockade (antagonism of apomorphine) for at least 30 days after treatment.5It is not known whether these extended effects of neuroleptics are due to continued presence of drug in tissue or to long-lasting physiologic changes that are a consequence of exposure to drug. Plasma elimination half-lives for neuroleptics in humans and rats are reported typically to be about 24 hours.4ThisKeywords
This publication has 4 references indexed in Scilit:
- Prolonged Pharmacologic Activity of Neuroleptic DrugsArchives of General Psychiatry, 1987
- Neurometabolic and behavioural effects of haloperidol in relation to drug levels in serum and brainNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1977
- Physiologic and clinical effects of chlorpromazine and their relationship to plasma levelClinical Pharmacology & Therapeutics, 1972
- Chlorpromazine Plasma Levels and EffectsArchives of General Psychiatry, 1970